MarketCap
Facebook
X
Telegram
Country |
 Britain |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
128 M |
Market Cap[1] |
$ 90.8 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Mirum Pharmaceuticals
MIRM
|
$ 80.14 | 3.04 % | $ 4.02 B | Nasdaq Global Select Market |  USA |
 |
Inhibikase Therapeutics
IKT
|
$ 1.65 | 1.67 % | $ 162 M | Nasdaq Capital Market | USA |
 |
Immatics N.V.
IMTX
|
$ 6.73 | 2.0 % | $ 823 M | Nasdaq Global Select Market |  Germany |
 |
Immunic
IMUX
|
$ 6.97 | 0.56 % | $ 1.09 B | Nasdaq Global Select Market | USA |
 |
Immunovant
IMVT
|
$ 26.73 | 0.57 % | $ 4.88 B | Nasdaq Global Select Market | USA |
 |
MediciNova
MNOV
|
$ 1.42 | 0.69 % | $ 69.7 M | Nasdaq Global Market | USA |
 |
Iovance Biotherapeutics
IOVA
|
$ 13.62 | 3.59 % | $ 4.87 M | Nasdaq Global Market,SPB | USA |
|
Rezolute
RZLT
|
$ 3.58 | 0.12 % | $ 372 M | Nasdaq Capital Market | USA |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market |  Canada |
 |
Krystal Biotech
KRYS
|
$ 316.58 | 0.82 % | $ 9.16 B | Nasdaq Global Market,SPB | USA |
 |
Nektar Therapeutics
NKTR
|
$ 35.78 | 2.25 % | $ 604 M | Nasdaq Global Select Market,SPB | USA |
 |
NanoViricides
NNVC
|
$ 1.38 | 0.73 % | $ 27.9 M | NYSE American | USA |
 |
Grifols, S.A.
GRFS
|
$ 7.64 | 1.33 % | $ 5.19 B | Nasdaq Global Select Market |  Spain |
 |
Nurix Therapeutics
NRIX
|
$ 24.42 | 0.12 % | $ 2.12 B | Nasdaq Global Select Market,SPB | USA |
 |
Ocugen
OCGN
|
$ 0.78 | 0.06 % | $ 244 M | Nasdaq Capital Market | USA |
 |
Oragenics
OGEN
|
$ 0.43 | 1.69 % | $ 928 K | NYSE American | USA |
 |
Omeros Corporation
OMER
|
$ 16.2 | 1.95 % | $ 1.03 B | Nasdaq Global Select Market | USA |
 |
ORIC Pharmaceuticals
ORIC
|
$ 12.35 | 10.18 % | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
Aligos Therapeutics
ALGS
|
$ 4.86 | 3.06 % | $ 48 M | Nasdaq Global Select Market | USA |
 |
Alkermes plc
ALKS
|
$ 41.22 | 2.79 % | $ 6.79 B | Nasdaq Global Select Market |  Irlanda |
 |
Jazz Pharmaceuticals plc
JAZZ
|
$ 210.23 | 2.28 % | $ 12.8 B | Nasdaq Global Select Market | Irlanda |
 |
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.87 | 0.05 % | $ 5.21 M | Nasdaq Capital Market | USA |
 |
Kymera Therapeutics
KYMR
|
$ 104.78 | 1.23 % | $ 8.85 B | Nasdaq Global Market | USA |
 |
Praxis Precision Medicines
PRAX
|
$ 241.76 | 3.86 % | $ 5.44 B | Nasdaq Global Select Market,SPB | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.31 | 0.34 % | $ 138 M | Nasdaq Global Market |  Niderland |
 |
PTC Therapeutics
PTCT
|
$ 59.24 | 2.21 % | $ 4.71 B | Nasdaq Global Select Market,SPB | USA |
 |
Arcus Biosciences
RCUS
|
$ 22.12 | 1.26 % | $ 2.38 B | NYSE,SPB | USA |
|
Larimar Therapeutics
LRMR
|
$ 1.99 | 1.51 % | $ 165 M | Nasdaq Global Market | USA |
 |
Regeneron Pharmaceuticals
REGN
|
$ 790.74 | 0.01 % | $ 82.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Rafael Holdings
RFL
|
$ 1.39 | 2.8 % | $ 40.9 M | NYSE | USA |
 |
REGENXBIO
RGNX
|
$ 6.93 | 4.07 % | $ 357 M | Nasdaq Global Select Market,SPB | USA |
 |
Royalty Pharma plc
RPRX
|
$ 60.96 | 2.25 % | $ 26.2 B | Nasdaq Global Select Market | USA |
 |
Seer
SEER
|
$ 2.03 | 0.44 % | $ 112 M | Nasdaq Global Select Market | USA |
 |
PDS Biotechnology Corporation
PDSB
|
$ 1.13 | 0.62 % | $ 52.4 M | Nasdaq Capital Market | USA |
 |
SIGA Technologies
SIGA
|
$ 3.17 | 0.16 % | $ 227 M | Nasdaq Global Select Market | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 21.3 | 4.46 % | $ 1.02 T | Nasdaq Global Select Market |  France |
 |
Syndax Pharmaceuticals
SNDX
|
$ 12.9 | 0.89 % | $ 1.12 B | Nasdaq Global Select Market | USA |
 |
Soligenix
SNGX
|
$ 0.35 | 1.67 % | $ 1.82 M | Nasdaq Capital Market | USA |
 |
Intellia Therapeutics
NTLA
|
$ 11.42 | 0.71 % | $ 1.24 B | Nasdaq Global Market,SPB | USA |
|
Nuvation Bio
NUVB
|
$ 4.45 | 1.6 % | $ 1.52 B | NYSE | USA |
 |
Sarepta Therapeutics
SRPT
|
$ 17.1 | 0.03 % | $ 1.71 B | Nasdaq Global Select Market,SPB | USA |
 |
Processa Pharmaceuticals
PCSA
|
$ 1.69 | 0.6 % | $ 2.21 M | Nasdaq Global Select Market | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
$ 0.48 | 0.2 % | $ 5.91 B | Nasdaq Global Market |  Israel |
 |
SELLAS Life Sciences Group
SLS
|
$ 9.98 | 4.02 % | $ 1.09 B | Nasdaq Capital Market | USA |
|
Protara Therapeutics
TARA
|
$ 2.32 | 1.46 % | $ 99.4 M | Nasdaq Global Market | USA |
 |
Relay Therapeutics
RLAY
|
$ 16.28 | 1.41 % | $ 2.79 B | Nasdaq Global Market | USA |
 |
Pfizer
PFE
|
$ 29.58 | 0.54 % | $ 168 B | NYSE,SPB | USA |
 |
Supernus Pharmaceuticals
SUPN
|
$ 37.88 | 0.5 % | $ 2.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Takeda Pharmaceutical Company Limited
TAK
|
$ 19.67 | 1.08 % | $ 31.1 B | NYSE |  Japan |
 |
Revolution Medicines
RVMD
|
$ 177.96 | 0.22 % | $ 33.8 B | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.